VENOUS NEEDLE DISLODGEMENT

VENOUS NEEDLE DISLODGEMENT – A SAFETY PROBLEM

It all started 2008 when EDTNA/ERCA identified the gap of knowledge about VND -Venous Needle Dislodgement

And the question was – how and what can we do to increase the awareness about VND and the consequences if nobody acts?

10 YEARS ANNIVERSARY OF COLLABORATION!

EDTNA/ERCA AND REDSENSE MEDICAL CELEBRATES 10 YEARS OF COLLABORATION


The Core of the Association is to develop Educational materials and organize educational events like this Conference and several Seminars along Europe with the aim of providing tools and knowledge to HealthCare professionals as well as our Patients. To be able to work according to this Mission, it is of great importance to build up long-term relationship with our Partners and the Collaboration between EDTNA/ERCA and Redsense Medical is an evidence of this. It creates a continuity and consistency which results in relevant and up-to-date information and material.

img-1540201446427

THE OBJECTIVE OF THIS EDUCATIONAL TOOL ARE.

  • To increase healthcare professionals’ awareness of Minimizing the risk of VND
  • To provide an educational tool which include Patient Education
  • To implement this knowledge into practice and to improve patient quality of life
  • To encourage Teamwork among Nurse, Patient and Carer
  • To highlight the 12 steps which are extremely important 
  • To have easy access to the information
img-1540201666657
Presentation at the Plenary Session at the 47th International Conference in Genoa, Italy, September 15th, 2018 
img-1539950599798
Learn more about VND from the Application
How to add a Web Application to your Home Screen - iPhone
img-1540974921847
How to add a Web Application to your Home Screen - Android
img-1540974921847
BACKGROUND 1

According to the European Renal Care Providers Association, at the end of 2016 about 2.65 million patients received haemodialysis (HD) worldwide. In the EU, last year 329,000 patients received 49.8 million HD treatments.

http://ercpa.eu/index.php/facts-figures/

Vascular access complications are a major cause of morbidity, leading to a high percentage of hospitalisation and in some cases even death. 

References

Hurst J. A Costly Complication: Venous Needle Dislodgement. 2010.

Shander A, Hofmann A, Ozawa S, et al. Activity-based Costs of Blood   Transfusions in Surgical Patients at Four Hospitals. Transfusion, 2010; 50(4):753-765

BACKGROUND 2

ALL patients on HD are exposed to  VND - a potentially life-threatening complication during treatment. 

Currently the usual HD blood flow rate is ≥350ml/min. 

A dislodged needle can cause SEVERE BLOOD LOSS within a few minutes!


References

Hurst J. Venous Needle Dislodgement-A Universal Concern. European Nephrology, 2011;5(2):148–51.

Axley B, Speranza-Reid J, Williams H. Venous Needle Dislodgement in Patients on Hemodialysis.     Nephrology Nursing Journal, 2012; 39(6):435-445.


EDTNA/ERCA Secretariat

Källstorps Gård / Högs Byväg 118 / SE-246 55 Löddeköpinge / Sweden
Phone: +46 46 70 96 24 / secretariat@edtnaerca.org

Head Office

EDTNA/ERCA, Seestrasse 91, CH 6052 Hergiswil, Switzerland